Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant

Table 1 Criteria for the inclusion of early mammalian target of rapamycin inhibitor conversion studies

Study design	Prospective cohort design with a well-defined study population
Study group	Post renal transplant
Conversion time	Period of 2 wk to 6 mo post-transplant
Study size	> 30 patients
Length of follow-up	Any
Source	Peer-reviewed journals
Language	English
Outcome measure	Patient safety, exposure-response relationships, adverse events, and graft functioning and long-term survival